American pharma major Eli Lilly's big focus on India: Will the company's strategy work?

American pharma major Eli Lilly sees India as its launchpad for a new growth trajectory, using its new drugs for diabetes and obesity as the fuel. Will this strategic pivot work? - Issue Date: Mar 31, 2024

Related Keywords

Germany ,India ,United States ,United Kingdom ,Vietnam ,Republic Of ,Denmark ,American ,Danish ,Sheetal Sapale ,Lilly Indian ,Sun Pharma ,Davida Ricks ,Zydus Lifesciences ,Vineet Gupta ,Eli Lilly ,National Family Health Survey ,Pfizer ,Drug Administration ,Cipla ,Company India Pvt ,Eli Lilly Co ,Novo Nordisk ,Eli Lilly Services India Pvt ,India Diabetes Report ,Indian Council ,Medical Research ,Eli Lilly Services India ,While Cipla ,Urbanisation ,Sedentary Lifestyles ,Pharmaceutical Companies ,Eli Lilly Amp Co ,Diabetes Obesity ,Type 2 Diabetes ,Mounjaro ,Zepbound ,Fda Approval ,Chronic Diseases ,Anti Obesity Drugs ,Harmaceutical Consumption ,Healthcare ,Indian Council Of Medical Research ,Psoriasis ,Alzheimer 039s Disease ,Breast Cancer ,Intellectual Property ,Manufacturing Capacity ,Pharmarack ,B2b Healthcare ,Lupin ,Dr Reddy S ,Ydus Lifesciences Issue Date Mar 31 ,024 ,